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REPLY 
Professor A. S. Breathnach, in his letter, raises some interestingly 
agreeable as well as controversial points of discussion which were, 
in our opinion, adequately discussed in our article published in 
the J Invest DermatoI 85(3) :222- 228, 1985. We carried out in vitro 
and in vivo studies to evaluate the selective melanocytotoxic and 
depigmenting property of azelaic acid (AZA) and to determine 
its value as a chemotherapeutic agent. O ur intent for these studies 
was to examine the effec ts of AZA on normal, proliferative, and 
m alignant melanocytes, at physiologic dose levels using the stan-
dard techniques of pigment cell research with which we have 
considerable experience. In black pigmented guinea pigs, the mel-
anocytotoxic effects of AZA , in terms of the inhibition of tyro-
sinase activity (dopa reaction), the melanocyte population, light 
and electron microscopic alterations in the morph ology of cells, 
and the clinical state of depigmentation, were compared w ith the 
known selective melanocytotoxic and depigmenting effects of 
po tent depigmenting agents such as 4-isopropylcatechol (4-IPC), 
4- hydroxyanisole (4-0 HA), hydroquinone (HQ), monobenzy-
lecher of hydroquinone (MBEHQ) , and monoethylether of hy-
droquinone (MEEHQ). AZA, even at 20% concentration, had 
little or no effect on proliferative melanocytes; contrary to this, 
4-IPC, 4-0 HA, MBEHQ, and MEEHQ were highly effective 
at 1 % concentration in inhibiting the growth of proliferative nor-
mal melanocytes. The effec t of AZA, as a chemotherapeutic agent, 
was evaluated in mice bearing subcutaneous B-1 6 melanoma tu-
m ors as well as mice bearing interperi toneally implanted B-1 6 
m elanoma tu inors. The in vivo effect of AZA on the growth and 
survival of S-91A (melanotic) and S-91 B (amelanotic) melanoma 
cells in culture was also examined. Our intentions were not to 
imply AZ A is not a benefi cial and therapeutic agent, especially 
for patients with lentigo maligna, but simply to demonstrate AZA 
at physiologic concentrations of 10- 5 to 10- 3 M does not exhibit 
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significant selective cytotoxic activity against pigmented no rmal 
melanocytes and against S-91 A (melanotic) and S-91 B (am elan_ 
otic) melan?ma cells. Importantly , significant in vivo inhibitory 
actIvIty aga1l1st transplantable tumor was not detected at diffe r en t 
concentrations. O ur data stand as published, and obviously t he 
comparison of results on di fferent species under different COn_ 
ditions does not appear to be valid , at leas t in the case of AZA. 
We agree the action mechanism of most melanocytotoxic agents 
may involve: (1) the di rect action on DNA synthesis involving 
S-phase toxicity; (2) an oxidant altering the oxidoreductase en_ 
zymes in energy-generating processes; (3) alterations on cellmern_ 
brane lipids and surfa ce permeability; or (4) indirect effects m e_ 
diated by the generation of reactive metaboli tes (e.g ., ·OH free_ 
radicals, semiquinones, and reactive oxygen species such as IO? 
Oi- , ·OOH, etc.). The free radi cals or reactive oxidation produc~~ 
of the depigmenting agent m ay affect the structural and fun ctional 
activity of cell membranes, mitochondria, or microsomes. It is 
probable that different mechanisms predominate different COrn_ 
pounds. The effects of AZA appear to be manifested at high 
concentrations exceedmg 10 - 3 M. The potent melanocytotox ic 
agents (e.g ., 4-IPC, 4-0HA, MBEHQ, and MEEHQ) not o nly 
inhibit DNA synthesis as a fun ction of concentration but also 
generate reactive free radi cals and oxygen species that affect the 
structural and fun ctional activity of cell membranes, mitochon_ 
dria, melanosomes, and microsomal enzymes at low concentra_ 
tions «10 - 3 M ) in both normal and I?roliferative abnormal m el_ 
anocytes . 
Madhu A. Pathak, Ph .D 
Michael M . Wick, M .D . , Ph.D · 
H arvard Medical Sch ooi 
Boston , Massachusetts 
Increase in Antigenicity of Basement Membrane Zone Antigens In Bullous 
Pemphigoid 
To the Editor: 
In a very interestin g article published in the July 1985 supplement 
iss ue [1], Jordon, Kawa na, and Fritz proposed the fo llowing 
mechanism of tissue injury in bullous pemphigoid : bullous pem-
ph igoid antigen in some way rendered immunogenic.to stimulate 
an antiself clone of B cell / plas ma cell s. 
Years ago we reported experiments demonstratin g that the 
action of proteolytic enzymes and galactosidases coul d expose 
hidden antigens of the basement membrane zone (BMZ) of the 
human skin that we called "activation of antigens" [2]. This was 
detected in the course of experim ents to delineate the antigenic 
structures of the antibody-binding sites for BMZ antibodies of 
pat ients with pemphigoid. Therefore, we stud ied the action of 
various enzymes in vitro, using the indirect immunoflu orescence 
method. We fo un d that a moderate expos ure of cryosta t sections 
of human skin to the ac tion of proteolytic enzy mes (papain and 
trypsin) and galactosidases increased antibody-binding capacity 
of the BMZ fo r BM Z antibodies , as demonstrated by an increased 
intensity of flu orescence of the BMZ and by an increase of titer-
dilution steps as compared with control sections not previously 
incubated [3). 
As regards the signifi cance of proteolytic enzy mes in the path-
ogenesis of bulla formation, Sti.i ttgen and Wiist [4] were able to 
demonstrate di- and tripeptidases regularly in blister fluid . A nd 
accordin g to studies o f B ra un-Falco [5], the action of trypsin and 
chymotrypsin on fresh, li ving skin res ults in separation of the 
epidermis and cutis and the histologic findin gs resemble those of 
bullous pemphigoid . 
Therefore, we have developed the hypothesis that a moderate 
action of pro teolyti c enzymes on BMZ antigens of the hu man 
skin markedl y increases the basement-membrane antibody-bind_ 
ing sites, indica ting an expos ure of hidden antigens. An increase 
in anti genicity could lead to the formation of autoantibodies of 
the basement-membrane antibody type [2,3,6). 
Furtherm ore, this mechanism-exposure of hidden antigens-
was shown in other experiments for the glomerular basement 
membrane too: Fillit et al (7) demonstra ted that patients with 
glomerul oneph ritis had a signifi cant blas togenic response to the 
glycosidase-trea ted glomerular basement membrane as compared 
with patients with nonglomerular renal discase and normal con-
trols. They suggested that removal of peripheral carbohyrate res-
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idues from glycopeptides fro m the basement membrane w ith 
g lycosidase exposed hidden antigens, resultin g in an autoimmune 
reacti on to altered g lomerular base ment membrane. 
Professor W. Remy 
T echni cal Uni versity of Munich 
Munich, F.R.G. 
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REPLY 
We read with interest the hypothesis proposed by Professor Remy 
concerning the action of proteolytic enzymes on the basement 
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membrane zone (BMZ) antigens. It certainl y is possible that some 
proteolytic enzymes may, as we state in our article, " in some 
way" render bullous pemphigoid antigen immunogenic. The 
problem is that the studies outlined in Professor Rem y's letter do 
not directl y support his hypothesis. 
It is not surprising that prior exposure of the BMZ to enzymes 
such as trypsin or chymotrypsin , as reported by Braun-Falco [11. 
results in subepidermal separation. Such studies merely indica te 
that the BMZ is susceptible to the action of these enzymes, and 
the ac tion of other proteolytic enzy mes could conceivably result 
in the same phenomenon . It is also not surprising that prior ex-
posure of the BMZ to a variety of enzymes might en hance the 
interaction of pemphigoid antibodies with their target antigens. 
Such treatment, as Professo r Remy has shown [2]. exposes ad-
ditional antigenic determinants for interac tion with pemphigoid 
an tibodies. Indeed , such a mechanism may be important as an 
amplifying event in blister formation in bullous pemphigoid through 
th e action of enzymes released from inflammato ry cells vi a pem-
phigoid antibody and complement [3). If enzymes are the trig-
gerin g event in bullous pemphigoid as suggested by Professor 
Remy, it is far from proven. Professor Rem y's hypothesis, like 
many of our own, must awa it additional investigations fo r ver-
ifi cation. 
Robert E. Jordon, M.D . 
Seiji Kawana , M.D . 
Karen A. Fritz, M .D. 
The University of T exas Health Science Center at H ouston 
Houston, Texas 
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Cellular Retinol-Binding Protein (CRBP) Is Measurable In Hun1.an Dern1.is 
To the Editor: 
Gates and King [1] reported in the September issue of the J ourn al 
interes tin g findin gs on the distribution of CRBP and C RABP in 
chick embryo dermis and epidermis and referred to our previous 
concordant work on human epidermis [2). In the N ovember issue, 
DiGiovanna et al [3] reported on human epidermis but did no t 
comment on our previous findin gs on the very same topic (the 
mail is probably much faster in N ashvi lle than in Bethesda!). This 
is unfortunate because they wou ld have had the opportunity to 
comment on both very concordant and very contrasting results 
on this important issue. 
The values obtained by both groups for CRBP and CRABP 
in the epidermis are very simi liar; DiGiovanna et al found 0.5 ± 
0.06 and 3.2 ± 0.45 pmol/mg protein for CRBP and CRABP, 
respectively, while we have found 1.0 ± 0.22 and 3. 1 ± 0.7 
pmol/m g protein. This is very encouraging for future work on 
this topic in human skin because epiderm al sepa ration differed in 
the 2 studies (EDT A vs hea t separation) and the techniques llsed 
were also different (sucrose density gradient analysis vs gel fi l-
tration analysis and determination of appa rent Kd). 
In contrast to our fi ndings, DiGiovanna et al were unable to 
detect either CRBP or CRABP in human dermis. Yet, we have 
found identical amounts of C RBP in dermis and epidermis sam-
ples and also low but detectable amounts ofCRABP in th e dermis. 
Several technica l points may explain the fai lure of DiGiovanna ct 
al to detect these proteins in the dermis. 
A. The gel filtration we used is probably m ore sensitive than 
the sucrose density gradient ana lysis. Indeed the baselines of gel 
filtration profiles are very low (2); this is no t the case with sucrose 
density g radient, as shown in Fig l a and lb of DiGiovanna 's 
report . 
